levofloxacin has been researched along with cantharidin in 1 studies
| Studies (levofloxacin) | Trials (levofloxacin) | Recent Studies (post-2010) (levofloxacin) | Studies (cantharidin) | Trials (cantharidin) | Recent Studies (post-2010) (cantharidin) |
|---|---|---|---|---|---|
| 4,346 | 581 | 2,209 | 875 | 27 | 307 |
| Protein | Taxonomy | levofloxacin (IC50) | cantharidin (IC50) |
|---|---|---|---|
| Protein phosphatase 1B | Homo sapiens (human) | 1.78 | |
| Tyrosine-protein phosphatase non-receptor type 1 | Homo sapiens (human) | 3.6 | |
| Serine/threonine-protein phosphatase PP1-gamma catalytic subunit | Homo sapiens (human) | 1.78 | |
| Serine/threonine-protein phosphatase 2A 55 kDa regulatory subunit B | Gallus gallus (chicken) | 0.63 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Andrews, JM; Child, J; Chow, AT; Mortiboy, D; Wise, R | 1 |
1 trial(s) available for levofloxacin and cantharidin
| Article | Year |
|---|---|
Open-label crossover study to determine pharmacokinetics and penetration of two dose regimens of levofloxacin into inflammatory fluid.
Topics: Adolescent; Adult; Anti-Infective Agents; Cantharidin; Cross-Over Studies; Drug Administration Schedule; Exudates and Transudates; Half-Life; Humans; Inflammation; Levofloxacin; Male; Middle Aged; Ofloxacin | 1995 |